Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients

Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients

Introduction: Vancomycin is widely prescribed to treat or prevent Gram-positive infections in pediatric liver transplant recipients. The objective of this prospective cohort study is to describe vancomycin pharmacokinetics and to evaluate the therapeutic target attainment after initial dose regimen....

Full description

Bibliographic Details
Main Authors:	Ronaldo Morales Junior, Vanessa D'Amaro Juodinis, Daniela Carla de Souza, Silvia Regina Cavani Jorge Santos
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Vancomycin Pharmacokinetics Pediatrics Liver transplantation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867023009480

Similar Items

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients
by: Kensuke Shoji, et al.
Published: (2021-10-01)

Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
by: Erin Chung, et al.
Published: (2021-04-01)

Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
by: Hillary Orr, et al.
Published: (2017-08-01)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
by: Kui-fen Ma, et al.
Published: (2020-10-01)

Vancomycin population pharmacokinetic modeling in children using Bayesian estimation and a Non Parametric Approach
by: Anna Luísa Oliveira Silveira, et al.
Published: (2022-06-01)

Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
by: Maryam Taghizadeh Ghehi, et al.
Published: (2013-12-01)

Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met
by: Talita Muniz Maloni, et al.
Published: (2019-07-01)

Predictive performance of Vancomycin population pharmacokinetic models in Iranian patients underwent hematopoietic stem cell transplantation
by: Maryam Taghizadeh-Ghehi, et al.
Published: (2015-01-01)

Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections
by: Kai Shen, et al.
Published: (2021-04-01)

Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function
by: De-Yi Li, et al.
Published: (2021-09-01)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023-06-01)

Clinical pharmacokinetics of vancomycin in the neonate: a review
by: Gian Maria Pacifici, et al.
Published: (2012-07-01)

Vancomycin pharmacokinetics in preterm infants Farmacocinética da vancomicina em neonatos pré-termo
by: Jose Kleber Kobol Machado, et al.
Published: (2007-01-01)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
by: Romain Garreau, et al.
Published: (2021-10-01)

Beta-Lactams Therapeutic Monitoring in Septic Children–What Target Are We Aiming for? A Scoping Review
by: Ronaldo Morales Junior, et al.
Published: (2022-03-01)

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
by: Katip W, et al.
Published: (2016-11-01)

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01)

Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
by: Oscar Santalo, et al.
Published: (2016-11-01)

Sorting Out the Risks and Benefits of the #797 Recommended Intrapartum Vancomycin Dosing Approach
by: Andras Farkas, et al.
Published: (2022-12-01)

Drug Utilization Evaluation of Vancomycin in Pediatric Department
by: Farzaneh Dehghan, et al.
Published: (2018-01-01)

Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
by: Medha D. Joshi, et al.
Published: (2023-05-01)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010-09-01)

Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
by: Muhammad Muaaz Munir, et al.
Published: (2021-11-01)

Monitoring of Serum Vancomycin Concentrations in Pediatric Patients with Normal Renal Function
by: Ghamar Taj Khotaei, et al.
Published: (2010-03-01)

Monitoring of Serum Vancomycin Concentrations in Pediatric Patients with Normal Renal Function
by: Ghamar Taj Khotaei, et al.
Published: (2010-04-01)

Population Pharmacokinetics of Vancomycin in Pregnant Women
by: Rahul K. Goyal, et al.
Published: (2022-06-01)

Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment
by: Ahmed KA, et al.
Published: (2024-01-01)

Evaluation of vancomycin individualized model-based dosing approach in neonates
by: Manal Abouelkheir, et al.
Published: (2023-05-01)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
by: Manon Tauzin, et al.
Published: (2019-05-01)

Transplantation of a kidney from a donor with vancomycin-resistant Enterococci
by: Ji Hye Lim, et al.
Published: (2020-06-01)

Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation
by: Chien-Chih Wu, et al.
Published: (2016-07-01)

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
by: Zhi-ling Li, et al.
Published: (2018-06-01)

External Evaluation of Vancomycin Population Pharmacokinetic Models at Two Clinical Centers
by: Yi-Xi Liu, et al.
Published: (2021-03-01)

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
by: Kashif Hussain, et al.
Published: (2022-08-01)

Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients
by: Guodong Li, et al.
Published: (2024-03-01)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
by: Jihui Chen, et al.
Published: (2021-12-01)

Rapid Colloidal Gold Immunoassay for Pharmacokinetic Evaluation of Vancomycin in the Cerebrospinal Fluid and Plasma of Beagle Dogs
by: Yechang Guo, et al.
Published: (2023-11-01)

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
by: Shu-Ping Liu, et al.
Published: (2022-11-01)

Pharmacokinetics of vancomycin in patients with different renal function levels
by: Zaric Radica Zivkovic, et al.
Published: (2018-10-01)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021-12-01)